Amgen Drug Wins US Approval for Type of Advanced Lung Cancer

Amgen Inc. won US approval for a new drug to treat a particularly aggressive form of advanced lung cancer, providing a badly needed new option for patients when chemotherapy stops working.

Related Keywords

Germany , United States , Americans , German , Boehringer Ingelheim Gmb , Astrazeneca Imfinzi , Robert Langreth , Jay Bradner , Drug Administration , Amgen , Merck Co , Harpoon Therapeutics Inc , New England Journal , Harpoon Therapeutics , Boehringer Ingelheim Gmbh ,